Biomarker Strategy in the Clinical Development of Ferroptosis-Based Cancer Therapy
- Overview of FerroptoCure’s biomarker strategy to support the clinical development of ferroptosis-based cancer therapies
- Current progress and future direction in identifying biomarkers for pharmacodynamic response and clinical utility in refractory cancers such as TNBC